Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

LPI (LP Information)' newest research report, the “Diagnostic Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Diagnostic Radiopharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostic Radiopharmaceuticals sales for 2023 through 2029. With Diagnostic Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Radiopharmaceuticals industry.

This Insight Report provides a comprehensive analysis of the global Diagnostic Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Diagnostic Radiopharmaceuticals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Radiopharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Radiopharmaceuticals.

The global Diagnostic Radiopharmaceuticals market size is projected to grow from US$ 4289.7 million in 2022 to US$ 6959.8 million in 2029; it is expected to grow at a CAGR of 6959.8 from 2023 to 2029.

North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.

This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Technetium 99
    Fluorine 18
    Other

Segmentation by application
    Oncology
    Cardiology
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Cardinal Health
    GE Healthcare
    Curium Pharma
    Jubilant Pharma
    Bracco Imaging
    Advanced Accelerator Applications
    SIEMENS
    China Isotope & Radiation
    Dongcheng Pharmaceutical Group
    Lantheus
    Eli Lilly

Key Questions Addressed in this Report
What is the 10-year outlook for the global Diagnostic Radiopharmaceuticals market?
What factors are driving Diagnostic Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostic Radiopharmaceuticals market opportunities vary by end market size?
How does Diagnostic Radiopharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Diagnostic Radiopharmaceuticals Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Technetium 99
    Table 4. Major Players of Fluorine 18
    Table 5. Major Players of Other
    Table 6. Global Diagnostic Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
    Table 7. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2018-2023)
    Table 8. Global Diagnostic Radiopharmaceuticals Revenue by Type (2018-2023) & ($ million)
    Table 9. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
    Table 10. Global Diagnostic Radiopharmaceuticals Sale Price by Type (2018-2023) & (US$/Unit)
    Table 11. Global Diagnostic Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
    Table 12. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2018-2023)
    Table 13. Global Diagnostic Radiopharmaceuticals Revenue by Application (2018-2023)
    Table 14. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
    Table 15. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2018-2023) & (US$/Unit)
    Table 16. Global Diagnostic Radiopharmaceuticals Sales by Company (2018-2023) & (K Units)
    Table 17. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2018-2023)
    Table 18. Global Diagnostic Radiopharmaceuticals Revenue by Company (2018-2023) ($ Millions)
    Table 19. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2018-2023)
    Table 20. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2018-2023) & (US$/Unit)
    Table 21. Key Manufacturers Diagnostic Radiopharmaceuticals Producing Area Distribution and Sales Area
    Table 22. Players Diagnostic Radiopharmaceuticals Products Offered
    Table 23. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Diagnostic Radiopharmaceuticals Sales by Geographic Region (2018-2023) & (K Units)
    Table 27. Global Diagnostic Radiopharmaceuticals Sales Market Share Geographic Region (2018-2023)
    Table 28. Global Diagnostic Radiopharmaceuticals Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 29. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region (2018-2023)
    Table 30. Global Diagnostic Radiopharmaceuticals Sales by Country/Region (2018-2023) & (K Units)
    Table 31. Global Diagnostic Radiopharmaceuticals Sales Market Share by Country/Region (2018-2023)
    Table 32. Global Diagnostic Radiopharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
    Table 33. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Country/Region (2018-2023)
    Table 34. Americas Diagnostic Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
    Table 35. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country (2018-2023)
    Table 36. Americas Diagnostic Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
    Table 37. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
    Table 38. Americas Diagnostic Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
    Table 39. Americas Diagnostic Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
    Table 40. APAC Diagnostic Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
    Table 41. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region (2018-2023)
    Table 42. APAC Diagnostic Radiopharmaceuticals Revenue by Region (2018-2023) & ($ Millions)
    Table 43. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2018-2023)
    Table 44. APAC Diagnostic Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
    Table 45. APAC Diagnostic Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
    Table 46. Europe Diagnostic Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
    Table 47. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2018-2023)
    Table 48. Europe Diagnostic Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
    Table 49. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
    Table 50. Europe Diagnostic Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
    Table 51. Europe Diagnostic Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
    Table 52. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
    Table 53. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2018-2023)
    Table 54. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue by Country (2018-2023) & ($ Millions)
    Table 55. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country (2018-2023)
    Table 56. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Type (2018-2023) & (K Units)
    Table 57. Middle East & Africa Diagnostic Radiopharmaceuticals Sales by Application (2018-2023) & (K Units)
    Table 58. Key Market Drivers & Growth Opportunities of Diagnostic Radiopharmaceuticals
    Table 59. Key Market Challenges & Risks of Diagnostic Radiopharmaceuticals
    Table 60. Key Industry Trends of Diagnostic Radiopharmaceuticals
    Table 61. Diagnostic Radiopharmaceuticals Raw Material
    Table 62. Key Suppliers of Raw Materials
    Table 63. Diagnostic Radiopharmaceuticals Distributors List
    Table 64. Diagnostic Radiopharmaceuticals Customer List
    Table 65. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K Units)
    Table 66. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 67. Americas Diagnostic Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
    Table 68. Americas Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 69. APAC Diagnostic Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K Units)
    Table 70. APAC Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 71. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
    Table 72. Europe Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 73. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K Units)
    Table 74. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 75. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2024-2029) & (K Units)
    Table 76. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 77. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2024-2029) & (K Units)
    Table 78. Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 79. Cardinal Health Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 80. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 81. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 82. Cardinal Health Main Business
    Table 83. Cardinal Health Latest Developments
    Table 84. GE Healthcare Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 85. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 86. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 87. GE Healthcare Main Business
    Table 88. GE Healthcare Latest Developments
    Table 89. Curium Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 90. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 91. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 92. Curium Pharma Main Business
    Table 93. Curium Pharma Latest Developments
    Table 94. Jubilant Pharma Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 95. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 96. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 97. Jubilant Pharma Main Business
    Table 98. Jubilant Pharma Latest Developments
    Table 99. Bracco Imaging Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 100. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 101. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 102. Bracco Imaging Main Business
    Table 103. Bracco Imaging Latest Developments
    Table 104. Advanced Accelerator Applications Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 105. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 106. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 107. Advanced Accelerator Applications Main Business
    Table 108. Advanced Accelerator Applications Latest Developments
    Table 109. SIEMENS Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 110. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 111. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 112. SIEMENS Main Business
    Table 113. SIEMENS Latest Developments
    Table 114. China Isotope & Radiation Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 115. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 116. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 117. China Isotope & Radiation Main Business
    Table 118. China Isotope & Radiation Latest Developments
    Table 119. Dongcheng Pharmaceutical Group Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 120. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 121. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 122. Dongcheng Pharmaceutical Group Main Business
    Table 123. Dongcheng Pharmaceutical Group Latest Developments
    Table 124. Lantheus Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 125. Lantheus Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 126. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 127. Lantheus Main Business
    Table 128. Lantheus Latest Developments
    Table 129. Eli Lilly Basic Information, Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
    Table 130. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolios and Specifications
    Table 131. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 132. Eli Lilly Main Business
    Table 133. Eli Lilly Latest Developments
List of Figures
    Figure 1. Picture of Diagnostic Radiopharmaceuticals
    Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Diagnostic Radiopharmaceuticals Sales Growth Rate 2018-2029 (K Units)
    Figure 7. Global Diagnostic Radiopharmaceuticals Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Diagnostic Radiopharmaceuticals Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Technetium 99
    Figure 10. Product Picture of Fluorine 18
    Figure 11. Product Picture of Other
    Figure 12. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type in 2022
    Figure 13. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
    Figure 14. Diagnostic Radiopharmaceuticals Consumed in Oncology
    Figure 15. Global Diagnostic Radiopharmaceuticals Market: Oncology (2018-2023) & (K Units)
    Figure 16. Diagnostic Radiopharmaceuticals Consumed in Cardiology
    Figure 17. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2018-2023) & (K Units)
    Figure 18. Diagnostic Radiopharmaceuticals Consumed in Other
    Figure 19. Global Diagnostic Radiopharmaceuticals Market: Other (2018-2023) & (K Units)
    Figure 20. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2022)
    Figure 21. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application in 2022
    Figure 22. Diagnostic Radiopharmaceuticals Sales Market by Company in 2022 (K Units)
    Figure 23. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2022
    Figure 24. Diagnostic Radiopharmaceuticals Revenue Market by Company in 2022 ($ Million)
    Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2022
    Figure 26. Global Diagnostic Radiopharmaceuticals Sales Market Share by Geographic Region (2018-2023)
    Figure 27. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Geographic Region in 2022
    Figure 28. Americas Diagnostic Radiopharmaceuticals Sales 2018-2023 (K Units)
    Figure 29. Americas Diagnostic Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
    Figure 30. APAC Diagnostic Radiopharmaceuticals Sales 2018-2023 (K Units)
    Figure 31. APAC Diagnostic Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
    Figure 32. Europe Diagnostic Radiopharmaceuticals Sales 2018-2023 (K Units)
    Figure 33. Europe Diagnostic Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
    Figure 34. Middle East & Africa Diagnostic Radiopharmaceuticals Sales 2018-2023 (K Units)
    Figure 35. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue 2018-2023 ($ Millions)
    Figure 36. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2022
    Figure 37. Americas Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2022
    Figure 38. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Type (2018-2023)
    Figure 39. Americas Diagnostic Radiopharmaceuticals Sales Market Share by Application (2018-2023)
    Figure 40. United States Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Canada Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Mexico Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 43. Brazil Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 44. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2022
    Figure 45. APAC Diagnostic Radiopharmaceuticals Revenue Market Share by Regions in 2022
    Figure 46. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Type (2018-2023)
    Figure 47. APAC Diagnostic Radiopharmaceuticals Sales Market Share by Application (2018-2023)
    Figure 48. China Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 49. Japan Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 50. South Korea Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 51. Southeast Asia Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 52. India Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 53. Australia Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 54. China Taiwan Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 55. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2022
    Figure 56. Europe Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2022
    Figure 57. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Type (2018-2023)
    Figure 58. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Application (2018-2023)
    Figure 59. Germany Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 60. France Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 61. UK Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Italy Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Russia Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 64. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2022
    Figure 65. Middle East & Africa Diagnostic Radiopharmaceuticals Revenue Market Share by Country in 2022
    Figure 66. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Type (2018-2023)
    Figure 67. Middle East & Africa Diagnostic Radiopharmaceuticals Sales Market Share by Application (2018-2023)
    Figure 68. Egypt Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 69. South Africa Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Israel Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Turkey Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 72. GCC Country Diagnostic Radiopharmaceuticals Revenue Growth 2018-2023 ($ Millions)
    Figure 73. Manufacturing Cost Structure Analysis of Diagnostic Radiopharmaceuticals in 2022
    Figure 74. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
    Figure 75. Industry Chain Structure of Diagnostic Radiopharmaceuticals
    Figure 76. Channels of Distribution
    Figure 77. Global Diagnostic Radiopharmaceuticals Sales Market Forecast by Region (2024-2029)
    Figure 78. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Region (2024-2029)
    Figure 79. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2024-2029)
    Figure 80. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Type (2024-2029)
    Figure 81. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Application (2024-2029)
    Figure 82. Global Diagnostic Radiopharmaceuticals Revenue Market Share Forecast by Application (2024-2029)

Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape